ClinicalTrials.Veeva

Find clinical trials for Multiple Sclerosis (MS) in New York, NY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Sclerosis
Multiple Sclerosis
Relapsing-Remitting Multiple Sclerosis
Chronic Progressive Multiple Sclerosis
Amyotrophic Lateral Sclerosis
Motor Neuron Disease
Muscle Spasticity

Multiple Sclerosis (MS) trials near New York, NY, USA:

Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) (BEAT-MS)

of Best Available Therapy (BAT) for treatment-resistant relapsing multiple sclerosis (MS). Participants will be randomized...

Enrolling
Secondary Progressive Multiple Sclerosis
Relapsing Multiple Sclerosis
Biological: Best Available Therapy (BAT)
Procedure: Autologous Hematopoietic Stem Cell Transplantation

Phase 3

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

New York, New York, United States and 18 other locations

will evaluate the pharmacokinetics, safety and tolerability, and immunogenicity of ocrelizumab administered subcutaneously to participants with multiple...

Active, not recruiting
Multiple Sclerosis (MS)
Drug: Ocrelizumab
Drug: rHuPH20

Phase 1

Roche
Roche

New York, New York, United States and 20 other locations

CT-100 is a platform that provides interactive, software based therapeutic components that may be used as part of a treatment in future software-base...

Enrolling
Multiple Sclerosis
Breast Cancer
Device: CT-100-D-004-A
Device: CT-100-D-004-B
Click Therapeutics
Click Therapeutics

New York, New York, United States

Locations recently updated

To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...

Enrolling
Multiple Sclerosis
Drug: Placebo capsule
Drug: Fingolimod

Phase 3

Novartis
Novartis

New Brunswick, New Jersey, United States and 107 other locations

with fingolimod in children and adolescents with relapsing-remitting multiple sclerosis aged between 10 and < 18 years over a durat...

Enrolling
Relapsing-Remitting Multiple Sclerosis
Other: Ocrelizumab Placebo
Other: Fingolimod Placebo

Phase 3

Roche
Roche

New York, New York, United States and 115 other locations

This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofat...

Enrolling
Relapsing-Remitting Multiple Sclerosis
Drug: Ofatumumab
Drug: Disease modifying treatment (DMT)

Phase 4

Novartis
Novartis

Neptune, New Jersey, United States and 32 other locations

Open-label study to evaluate the effectiveness of treatment with ofatumumab in subjects transitioning from any fumarate-based RMS approved therapy or...

Active, not recruiting
Relapsing Multiple Sclerosis
Biological: Ofatumumab

Phase 3

Novartis
Novartis

Woodmere, New York, United States and 122 other locations

This study will evaluate the impact of ofatumumab in Relapsing Remitting Multiple Sclerosis (RRMS) participants that are very early...

Enrolling
Relapse Remitting Multiple Sclerosis
Drug: Ofatumumab

Phase 4

Novartis
Novartis

Hackensack, New Jersey, United States and 39 other locations

(maintenance) in people with systemic lupus erythematosus (lupus), infantile spasms, adults with acute relapses or flares of multiple sclerosis...

Enrolling
Scleritis
Drug: ACTH (adrenocorticotropic hormone) gel

Phase 2

Metropolitan Eye Research & Surgery Institute

Palisades Park, New Jersey, United States of America and 2 other locations

memory, and gait therapy in persons with walking disability due to Multiple Sclerosis. The study will evaluate the mobility, learni ...

Enrolling
Multiple Sclerosis
Cognitive Impairment
Device: Robotic Exoskeleton Rehabilitation
Other: Conventional Gait Therapy
Kessler Foundation
Kessler Foundation

West Orange, New Jersey, United States

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems